Interpace Biosciences, Inc. financial data

Symbol
IDXG on OTC
Location
Waterview Plaza, Suite 310, 2001 Route 46, Parsippany, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 116 % +23.3%
Quick Ratio 12.1 % +11.9%
Debt-to-equity -117 % -179%
Return On Equity -33.5 % -356%
Return On Assets 32.8 % +6.88%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.42M shares +0.66%
Common Stock, Shares, Outstanding 4.42M shares +1.07%
Entity Public Float 4M USD +5.65%
Common Stock, Value, Issued 407K USD +0.25%
Weighted Average Number of Shares Outstanding, Basic 4.42M shares +1.07%
Weighted Average Number of Shares Outstanding, Diluted 4.42M shares +0.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 45.5M USD +9.38%
Cost of Revenue 17M USD +7.98%
Research and Development Expense 743K USD +27.2%
Selling and Marketing Expense 11.7M USD +6.16%
General and Administrative Expense 10.3M USD +23.5%
Operating Income (Loss) 5.72M USD +1.33%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.86M USD +14.8%
Income Tax Expense (Benefit) 18K USD +5.88%
Net Income (Loss) Attributable to Parent 4.56M USD +13.4%
Earnings Per Share, Basic 0 USD/shares +1.09%
Earnings Per Share, Diluted 0 USD/shares -143%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 502K USD +0.4%
Accounts Receivable, after Allowance for Credit Loss, Current 7.23M USD +16.5%
Inventory, Net 973K USD -21%
Other Assets, Current 1.77M USD -8.76%
Assets, Current 9.5M USD +0.04%
Property, Plant and Equipment, Net 1.37M USD +21.3%
Operating Lease, Right-of-Use Asset 1.42M USD -13.2%
Other Assets, Noncurrent 45K USD 0%
Assets 12.3M USD -4.91%
Accounts Payable, Current 1.25M USD -29%
Employee-related Liabilities, Current 2.05M USD +64.5%
Liabilities, Current 7.15M USD +0.69%
Long-term Debt and Lease Obligation 1.75M USD -41.1%
Operating Lease, Liability, Noncurrent 974K USD -24.3%
Other Liabilities, Noncurrent 5.43M USD +5.42%
Liabilities 13.5M USD -27.6%
Retained Earnings (Accumulated Deficit) -234M USD +1.91%
Stockholders' Equity Attributable to Parent -1.21M USD +97.7%
Liabilities and Equity 12.3M USD -4.91%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.24M USD
Net Cash Provided by (Used in) Financing Activities -1.5M USD -150%
Net Cash Provided by (Used in) Investing Activities -28K USD +56.9%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 4.56M shares +1.65%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -265K USD +61.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 502K USD -75.1%
Deferred Tax Assets, Valuation Allowance 35.1M USD -4.99%
Operating Lease, Liability 1.38M USD -14%
Payments to Acquire Property, Plant, and Equipment 28K USD -56.9%
Lessee, Operating Lease, Liability, to be Paid 1.65M USD -19.2%
Property, Plant and Equipment, Gross 4.21M USD +26.2%
Operating Lease, Liability, Current 406K USD +27.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 550K USD +10%
Lessee, Operating Lease, Liability, to be Paid, Year One 550K USD +22.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 270K USD -38.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 275K USD -50%
Deferred Tax Assets, Operating Loss Carryforwards 24.1M USD -3.43%
Preferred Stock, Shares Authorized 5M shares
Unrecognized Tax Benefits 877K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 275K USD
Amortization of Intangible Assets 900K USD -30.8%
Depreciation, Depletion and Amortization 95K USD +82.7%
Deferred Tax Assets, Net of Valuation Allowance 168K USD +700%
Share-based Payment Arrangement, Expense 183K USD -55.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares